ProMIS Neurosciences Files 2025 Proxy Statement
Ticker: PMN · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1374339
| Field | Detail |
|---|---|
| Company | Promis Neurosciences Inc. (PMN) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
ProMIS Neurosciences proxy filed - vote on board, pay, and strategy for June 12 meeting.
AI Summary
ProMIS Neurosciences Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting on June 12, 2025. The company, formerly known as Amorfix Life Sciences Ltd., is seeking shareholder approval for matters related to its corporate governance and operations. The filing details executive compensation, board nominations, and other shareholder proposals.
Why It Matters
This filing provides shareholders with crucial information to make informed decisions on company leadership and strategic direction at the upcoming annual meeting.
Risk Assessment
Risk Level: medium — Proxy statements can signal upcoming strategic shifts or governance changes that may impact stock price.
Key Players & Entities
- ProMIS Neurosciences Inc. (company) — Registrant
- Amorfix Life Sciences Ltd. (company) — Former company name
- June 12, 2025 (date) — Annual meeting date
- April 29, 2025 (date) — Filing date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting on June 12, 2025, including details on board nominations, executive compensation, and other corporate matters.
When is the annual meeting of ProMIS Neurosciences Inc. scheduled?
The annual meeting is scheduled for June 12, 2025.
What was ProMIS Neurosciences Inc. formerly known as?
ProMIS Neurosciences Inc. was formerly known as Amorfix Life Sciences Ltd.
On what date was this definitive proxy statement filed?
This definitive proxy statement was filed on April 29, 2025.
What is the standard industrial classification for ProMIS Neurosciences Inc.?
The standard industrial classification for ProMIS Neurosciences Inc. is Pharmaceutical Preparations [2834].
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding ProMIS Neurosciences Inc. (PMN).